Hui Huang | Precision Medicine | Best Researcher Award

Hui Huang | Precision Medicine | Best Researcher Award

Prof. Dr. Hui Huang, The Eighth Affiliated Hospital of Sun Yat-Sen University, China

Prof. Hui Huang is Vice President of The Eighth Affiliated Hospital of Sun Yat-sen University and a renowned expert in vascular calcification and chronic disease prevention. 📚 He has authored 100+ high-impact papers in journals like Circulation and J Clin Invest, earning honors like ESI Highly Cited and Top 100 High-Value Papers. 🏆 A recipient of China’s Excellent Young Scientists Fund, he directs multiple prestigious laboratories and holds several international patents. 🔬 His research explores metabolic and immune mechanisms in chronic kidney disease and vascular aging.

Publication Profile

Scopus

Education

Prof. Dr. Hui Huang has authored over 100 peer-reviewed papers in prestigious journals such as Circulation (2022, 2023), J Clin Invest. (2021, 2022, 2025), Hypertension (2018, 2021, 2022), STTT (2022–2024), Kidney Int. (2024), and Cardiovasc Res. (2023) 📚. His impactful work has earned distinctions like ESI Highly Cited Papers, Top 100 High-Value Papers, and journal Cover Stories 🏅. A recipient of China’s National Science Fund for Excellent Young Scholars 🎓, he also led the development of the Expert Consensus on Vascular Calcification, offering vital clinical guidance for practitioners in the field of cardiovascular and renal medicine ❤️🩺.

Experience

Prof. Dr. Hui Huang has led more than 13 major research projects, predominantly funded by the National Natural Science Foundation of China (NSFC) 🔬🇨🇳. His groundbreaking work focuses on unraveling the innovative mechanisms behind arterial calcification, chronic kidney disease, and inflammation 🧠🫀. These projects are long-term, high-budget, and scientifically robust, highlighting their critical importance on both national and global stages 🌍💰. Through his pioneering research, Prof. Huang is driving transformative advancements in cardiovascular and renal health, contributing significantly to medical science and improving patient outcomes 🚀🩺.

Research Focus

Prof. Dr. Hui Huang is a leading researcher in biomedical sciences, with a strong focus on cardiovascular disease, immunology, toxicology, and metabolic disorders. Her work spans areas such as inflammation in the central nervous system, myocardial infarction, diabetes-related metabolomics, and environmental health risks like metal toxicity. 🌡️🧠🫀 She also explores digital therapeutics and sex-based differences in disease outcomes, making her contributions highly interdisciplinary. 📊💻 Her research integrates clinical, molecular, and environmental insights to develop novel strategies for disease prevention and treatment. A strong advocate for translational medicine, Prof. Huang bridges lab science with real-world health challenges.

Publication Top Notes

The Innate Immune Sensor Zbp1 Mediates Central Nervous System Inflammation Induced by Angiostrongylus Cantonensis by Promoting Macrophage Inflammatory Phenotypes

Targeted LC-MS/MS method of oxylipin profiling reveals differentially expressed serum metabolites in type 2 diabetes mice with panaxynol

Ellagic acid-enhanced biocompatibility and bioactivity in multilayer core-shell gold nanoparticles for ameliorating myocardial infarction injury

Sex difference in human diseases: mechanistic insights and clinical implications

Effect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention

Digital therapeutics in hypertension: How to make sustainable lifestyle changes

Associations of essential metals with the risk of aortic arch calcification: a cross-sectional study in a mid-aged and older population of Shenzhen, China

Dr. Atefeh Nasir Kansestani|Diagnostic Test Accuracy|Women Researcher Award

Dr. Atefeh Nasir Kansestani | Diagnostic Test Accuracy|Women Researcher Award

Dr. Atefeh Nasir Kansestani atDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang,China

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Atefeh Nasir Kansestani was born on May 26, 1990, in Kermanshah, Iran. Her journey in the medical sciences began at the Kermanshah University of Medical Sciences, where she pursued a Bachelor of Science in Medical Laboratory Science (2009-2013). During her undergraduate studies, she excelled academically, achieving top ranks among her peers. She completed her Master’s in Medical Immunology (2013-2016), also at Kermanshah University of Medical Sciences, with a stellar GPA of 3.94 out of 4. Her thesis, supervised by Prof. Ali Mostafaie, investigated the expression of SIRT, NF-κB, and P53 in breast adenocarcinoma cell lines under different glucose conditions, laying the groundwork for her future interest in tumor biology and diagnostics. Atefeh is currently advancing her expertise with a Ph.D. in Clinical Laboratory Diagnostics at Zhejiang University, China (2021-present), where she is expanding her research into laboratory diagnostics and tumor biology.

Professional Endeavors 🧬

Atefeh has built a multifaceted career in laboratory science and diagnostics. She has held various positions at Kermanshah University of Medical Sciences, including her role as a Laboratory Supervisor for the SARS-CoV-2 Task Force during the COVID-19 pandemic. This critical position, which she began in February 2020, involved managing testing and research efforts in the SARS-CoV-2 Special Laboratory, ensuring high standards of public health service during a challenging time. Before this, Atefeh worked in the Reference Laboratory of Western Iran (2017-2019) and contributed to the Nosocomial Infection Research Center (2016-2017). Her commitment to health services also extends to her early work at the Medical Biology Research Center in Kermanshah, where she gained hands-on experience and skills in laboratory diagnostics.

In 2017, Atefeh was part of the Executive Committee for the 5th National and 1st International Congress on Novel and Innovative Laboratory Technologies. As a co-organizer, she contributed to the symposium’s success, helping bring together professionals and researchers to discuss advancements in laboratory science. Atefeh is also the Chairman of Exir Gharb Company, a prominent manufacturer of laboratory equipment and reagents. Founded in 2013, Exir Gharb specializes in producing blood collection tubes, including granulated serum separator tubes with clot activators. This product line was developed from Atefeh’s patent, demonstrating her entrepreneurial spirit and innovative approach to laboratory equipment.

Contributions and Research Focus 🔬

Atefeh’s research interests center on laboratory diagnostics and tumor biology, with a strong focus on biomolecular markers related to cancer progression and immune response. Her graduate research on the regulation of SIRT, NF-κB, and P53 in breast cancer cell lines provided insight into how glucose levels impact cancer cell behavior, a study relevant to understanding cancer in diabetic patients. Through her work at the COVID-19 Reference Laboratory and in diagnostics for HIV/AIDS and influenza, Atefeh has also contributed to understanding and managing infectious diseases, demonstrating her adaptability across various fields of medical science. Her expertise spans molecular diagnostics, tumor biology, and disease control, allowing her to make substantial contributions to both cancer and infectious disease research.

Accolades and Recognition 🏆

Throughout her academic and professional career, Atefeh has consistently demonstrated excellence. She has received multiple awards for her achievements, starting with the Top Student Award during her undergraduate studies at Kermanshah University of Medical Sciences in 2012 and 2013. In her Master’s program, she graduated at the top of her class in 2016, further reinforcing her reputation as a leading scholar. Atefeh’s dedication and expertise have been acknowledged through her effective cooperation in the Health Reference Laboratories for COVID-19 (2020-2021) and HIV/AIDS and influenza (2019), where she played a key role in managing public health crises.

Impact and Influence 🌍

Atefeh’s work has significantly impacted both her community in Iran and the broader medical research field. Her leadership during the COVID-19 pandemic, especially in establishing protocols and maintaining operational efficiency in the testing laboratory, has contributed to the health and safety of countless individuals in Western Iran. Additionally, her involvement in HIV/AIDS and influenza diagnostics has helped advance Kermanshah University of Medical Sciences as a vital center for infectious disease research and control. As a company leader at Exir Gharb, Atefeh has furthered regional development in laboratory technology, enhancing local accessibility to high-quality diagnostic tools.

Legacy and Future Contributions 🌠

Atefeh’s professional legacy is characterized by her drive to bridge academia, public health, and industry. Her innovations in laboratory equipment manufacturing, especially her patented blood collection tubes, showcase her contributions to advancing diagnostic technologies in Iran. Looking forward, Atefeh aims to continue her research in clinical diagnostics and tumor biology, leveraging her skills in bioinformatics, RNA-sequencing, and data analysis to explore new therapeutic and diagnostic pathways. Through her research and entrepreneurial efforts, Atefeh is well-positioned to become a thought leader and pioneer in laboratory diagnostics, making her an invaluable asset to the scientific and medical communities.

🎓Publication 

Descriptions of acute transfusion reactions in the teaching hospitals of Kermanshah University of Medical Sciences

  • Authors   : Mehrdad Payandeh, Nasrollah Sohrabi, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Amir Hossein Hashemian
  • Journal    :  hematology-oncology and stem cell research
  • Year         :2012

Sex Hormones and Prolactin Levels and Their Association with Anti Cardiolipin Antibody in Patients with Systemic Lupus Erythematosus

  • Authors   : Dariyush Raeisi, Atefeh Nasir Kansestani, Hamidraza Sherkatolabbasieh, Shiva Shafeizadeh
  • Journal    : Iranian Journal of Allergy, Asthma and Immunology
  • Year         :2018

Poor platelet count response to Helicobacter pylori eradication in patients with severe idiopathic thrombocytopenic purpura

  • Authors   :Mehrdad Payandeh, Dariyush Raeisi, Nasrollah Sohrabi, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Nazanin Keshavarz, Samira Gholami, Amir Hossein Hashemian
  • Journal    :International journal of hematology-oncology and stem cell research
  • Year         :2013

Kaposi’s sarcoma after kidney transplantation: A 21-years experience

  • Authors   :Dariyush Raeisi, Mehrdad Payandeh, Seyed Hamid Madani, Mohammad Erfan Zare, Atefeh Nasir Kansestani, Amir Hossein Hashemian
  • Journal    : International Journal of Hematology-Oncology and Stem Cell Research
  • Year         :2013

Procalcitonin has good accuracy for prognosis of critical condition and mortality in COVID-19: A diagnostic test accuracy systematic review and meta-analysis

  • Authors   : Mohammad Erfan Zare, Yanzhong Wang, Atefeh Nasir Kansestani, Afshin Almasi, Jun Zhang
  • Journal    :Iranian Journal of Allergy, Asthma and Immunology
  • Year         :2020